Verona Pharma PLC American Depositary Share (VRNA) Insider Trading & Ownership $86.86 -4.34 (-4.76%) Closing price 04:00 PM EasternExtended Trading$86.70 -0.16 (-0.18%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$188.93KNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$30.47M Get VRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Verona Pharma PLC American Depositary Share stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRNA Insider Buying and Selling by Quarter Verona Pharma PLC American Depositary Share Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2025Andrew FisherGeneral CounselSell80,000$11.53$922,400.00 6/11/2025David ZaccardelliCEOSell400,000$11.40$4,560,000.00 6/11/2025Mark W HahnCFOSell400,000$11.40$4,560,000.00 5/29/2025David ZaccardelliCEOSell208,696$9.33$1,947,133.68 5/29/2025Mark W HahnCFOSell204,864$9.33$1,911,381.12 5/28/2025David ZaccardelliCEOSell157,704$9.30$1,466,647.20 5/28/2025Mark W HahnCFOSell162,704$9.30$1,513,147.20 5/27/2025David ZaccardelliCEOSell33,600$9.53$320,208.00 5/27/2025Mark W HahnCFOSell32,432$9.53$309,076.96 5/6/2025Kathleen A RickardInsiderSell114,984$8.82$1,014,158.88 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/29/2025Andrew FisherGeneral CounselSell26,072$8.98$234,126.56 4/29/2025David ZaccardelliCEOSell90,360$8.98$811,432.80 4/29/2025Kathleen A RickardInsiderSell34,384$8.98$308,768.32 4/29/2025Vikas SinhaDirectorSell20,000$8.92$178,400.00 3/12/2025Kathleen A RickardInsiderSell79,264$8.35$661,854.40 12/6/2024David ZaccardelliCEOSell162,800$5.01$815,628.00 12/6/2024Mark W HahnCFOSell183,728$5.01$920,477.28 12/4/2024David ZaccardelliCEOSell67,608$5.00$338,040.00 12/4/2024Mark W HahnCFOSell58,184$5.00$290,920.00 12/2/2024David ZaccardelliCEOSell3,200$5.00$16,000.00 12/2/2024Mark W HahnCFOSell1,600$5.00$8,000.00 11/29/2024David ZaccardelliCEOSell98,888$5.01$495,428.88 11/29/2024Mark W HahnCFOSell98,704$5.01$494,507.04 11/27/2024David ZaccardelliCEOSell23,240$5.00$116,200.00 11/27/2024Mark W HahnCFOSell12,936$5.00$64,680.00 11/25/2024Kathleen A RickardInsiderSell240,000$4.90$1,176,000.00 11/25/2024Mark W HahnCFOSell1,600$5.00$8,000.00 11/11/2024David ZaccardelliCEOSell2,400$5.00$12,000.00 11/6/2024David R EbsworthDirectorBuy39,360$4.80$188,928.00 11/4/2024David ZaccardelliCEOSell94,144$4.39$413,292.16 11/4/2024Mark W HahnCFOSell80,784$4.39$354,641.76 11/1/2024David ZaccardelliCEOSell46,888$4.38$205,369.44 11/1/2024Mark W HahnCFOSell48,888$4.38$214,129.44 10/25/2024David ZaccardelliCEOSell4,800$4.38$21,024.00 10/24/2024Mark W HahnCFOSell141,360$4.38$619,156.80 10/23/2024David ZaccardelliCEOSell16$4.38$70.08 10/21/2024David ZaccardelliCEOSell110,456$4.38$483,797.28 10/21/2024Mark W HahnCFOSell116,696$4.38$511,128.48 10/18/2024David ZaccardelliCEOSell245,784$4.38$1,076,533.92 10/18/2024Mark W HahnCFOSell249,728$4.38$1,093,808.64 Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. (Data available from 1/1/2013 forward) VRNA Insider Trading Activity - Frequently Asked Questions Who is on Verona Pharma PLC American Depositary Share's Insider Roster? The list of insiders at Verona Pharma PLC American Depositary Share includes Andrew Fisher, Claire Poll, David R Ebsworth, David Zaccardelli, Kathleen A Rickard, Mark W Hahn, Martin Edwards, Orbimed Advisors Llc, and Vikas Sinha. Learn more on insiders at VRNA. What percentage of Verona Pharma PLC American Depositary Share stock is owned by insiders? 4.80% of Verona Pharma PLC American Depositary Share stock is owned by insiders. Learn more on VRNA's insider holdings. Which Verona Pharma PLC American Depositary Share insiders have been buying company stock? The following insiders have purchased VRNA shares in the last 24 months: David R Ebsworth ($505,728.00), and Martin Edwards ($62,074.24). How much insider buying is happening at Verona Pharma PLC American Depositary Share? Insiders have purchased a total of 233,096 VRNA shares in the last 24 months for a total of $567,802.24 bought. Which Verona Pharma PLC American Depositary Share insiders have been selling company stock? The following insiders have sold VRNA shares in the last 24 months: Andrew Fisher ($1,156,526.56), Claire Poll ($105,948.40), David Zaccardelli ($13,685,980.32), Kathleen A Rickard ($3,530,506.00), Mark W Hahn ($13,454,855.52), and Vikas Sinha ($178,400.00). How much insider selling is happening at Verona Pharma PLC American Depositary Share? Insiders have sold a total of 4,802,696 Verona Pharma PLC American Depositary Share shares in the last 24 months for a total of $32,112,216.80 sold. Verona Pharma PLC American Depositary Share Key ExecutivesDr. David S. Zaccardelli Pharm.D. (Age 60)President, CEO & Executive Director Compensation: $1.27MMr. Mark W. Hahn (Age 61)Chief Financial Officer Compensation: $858.29k4 recent tradesDr. Kathleen A. Rickard M.D. (Age 66)Chief Medical Officer Compensation: $650.83k3 recent tradesMr. Andrew Fisher (Age 54)General Counsel 2 recent tradesMs. Victoria StewartDirector of CommunicationsMr. Matthew CasbonVP of Sales, Marketing & TrainingMs. Ostra JewellSenior Vice President of Human ResourcesDr. Tara Rheault M.P.H. (Age 48)Ph.D., Chief Development Officer Mr. Christopher MartinChief Commercial OfficerMs. Caroline DiazSenior Vice President of Regulatory Affairs More Insider Trading Tools from MarketBeat Related Companies ONC Insider Selling BNTX Insider Selling TEVA Insider Selling SMMT Insider Selling ITCI Insider Selling GMAB Insider Selling MRNA Insider Selling VTRS Insider Selling BPMC Insider Selling BBIO Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors? This page (NASDAQ:VRNA) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma PLC American Depositary Share Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma PLC American Depositary Share With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
